Skip to main content
Clinical Trials/NL-OMON26603
NL-OMON26603
Completed
Not Applicable

Effect of a new disease-specific tube feed on the plasma glucose profile in type 2 diabetes patients.

Danone Research ¨C Centre for Specialised Nutrition0 sites24 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
type 2 diabetestype 2 diabetes patientsplasma glucose profile tube feeddisease-specificDM II
Sponsor
Danone Research ¨C Centre for Specialised Nutrition
Enrollment
24
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Danone Research ¨C Centre for Specialised Nutrition

Eligibility Criteria

Inclusion Criteria

  • Age/sex: males (age \>\= 18 yrs) or post\-menopausal females
  • \-Ambulant type 2 diabetes patients

Exclusion Criteria

  • \-Any gastrointestinal disease that interferes with bowel function and nutritional intake (i.e. diabetes related constipation or diarrhea secondary to neuropathy, diarrhea due to chronic inflammatory bowel disease, gastroparesis, gastrectomy)
  • \-Known heart failure, defined by New York Heart Association (NYHA) class IV

Outcomes

Primary Outcomes

Not specified

Similar Trials